These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2536870)

  • 1. Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS).
    Garcia C; Rosén A; Kimby E; Aguilar-Santelises M; Jondal M; Bjorkholm M; Holm G; Mellstedt H
    Leuk Res; 1989; 13(1):31-7. PubMed ID: 2536870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type (B-CLL) and monoclonal B-lymphocytosis of undetermined significance (B-MLUS).
    Kimby E; Mellstedt H; Nilsson B; Björkholm M; Holm G
    Leukemia; 1989 Jul; 3(7):501-4. PubMed ID: 2471902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population.
    Aman P; Mellstedt H
    Leuk Res; 1991; 15(8):715-9. PubMed ID: 1654482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis of undetermined significance.
    Kimby E; Mellstedt H; Björkholm M; Holm G
    Eur J Haematol; 1989 Nov; 43(5):452-9. PubMed ID: 2612619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of helper factors (IL-1 alpha, IL-1 beta and IL-6), T-cell products (sCD4 and sCD8), sIL-2R and beta 2-microglobulin in patients with B-CLL and benign B lymphocytosis.
    Aguilar-Santelises M; Loftenius A; Ljungh C; Svenson SB; Andersson B; Mellstedt H; Jondal M
    Leuk Res; 1992; 16(6-7):607-13. PubMed ID: 1386130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with Staphylococcus aureus and anti-CD40 monoclonal antibodies.
    Garcia CA; Rosén A; Aguilar-Santelises M; Jondal M; Mellstedt H
    Leuk Res; 1993 Nov; 17(11):933-9. PubMed ID: 8231234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD5-negative phenotype of monoclonal B-lymphocytosis of undetermined significance (MLUS).
    Wang C; Amato D; Fernandes B
    Am J Hematol; 2002 Feb; 69(2):147-9. PubMed ID: 11835355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL.
    Wang C; Amato D; Rabah R; Zheng J; Fernandes B
    Leuk Res; 2002 Dec; 26(12):1125-9. PubMed ID: 12443886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of adhesion molecules CD11/CD18 (Leu-CAMs, beta 2-integrins), CD54 (ICAM-1) and CD58 (LFA-3) in B-chronic lymphocytic leukemia.
    Kimby E; Rincón J; Patarroyo M; Mellstedt H
    Leuk Lymphoma; 1994 Apr; 13(3-4):297-306. PubMed ID: 7519509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
    Cordone I; Matutes E; Catovsky D
    Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome (DS) peripheral blood contains phenotypically mature CD3+TCR alpha, beta+ cells but abnormal proportions of TCR alpha, beta+, TCR gamma, delta+, and CD4+ CD45RA+ cells: evidence for an inefficient release of mature T cells by the DS thymus.
    Murphy M; Epstein LB
    Clin Immunol Immunopathol; 1992 Feb; 62(2):245-51. PubMed ID: 1530912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chronic lymphocytic leukemia with peripheral T lymphocytes expressing CD 2+, CD 3+, CD 4-, CD 8-, CD 16+, and CD 56+ and lymph-node lymphocytes expressing CD 2+, CD 3-, CD 4-, CD 8-, CD 16+, CD 38+, and CD 56+].
    Furukawa Y; Tanaka K; Hasuike T; Hirai M; Masuzawa K; Ohira H; Ota K; Yasui Y; Nakao Y; Inoue T
    Rinsho Byori; 1991 May; 39(5):557-61. PubMed ID: 1712868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD16+ NK cells decrease in all stages of HIV infection through a selective depletion of the CD16+CD8+CD3- subset.
    Mansour I; Doinel C; Rouger P
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1451-7. PubMed ID: 2150319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological variants of leukemic cells in B chronic lymphocytic leukemia are associated with different T cell and NK cell abnormalities.
    Reyes E; Prieto A; Carrion F; Garcia-Suarez J; Esquivel F; Alvarez-Mon M
    Am J Hematol; 1997 Aug; 55(4):175-82. PubMed ID: 9257876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: II. L-selectin expression mediated cell adhesion revealed by immobilized analogue carbohydrates in B-cell chronic lymphocytic leukaemia and monoclonal lymphocytosis of undetermined significance.
    Csanaky G; Vass JA; Losonczy H; Schmelczer M
    Med Oncol Tumor Pharmacother; 1993; 10(4):173-80. PubMed ID: 8164454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low IL-1 beta production in leukemic cells from progressive B cell chronic leukemia (B-CLL).
    Aguilar-Santelises M; Amador JF; Mellstedt H; Jondal M
    Leuk Res; 1989; 13(10):937-42. PubMed ID: 2586147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37].
    Garcia C; Rosén A; Kimby E; Aguilar-Santelises M; Jondal M; Björkholm M; Holm G; Mellstedt H
    Leuk Res; 2017 Jun; 57():127. PubMed ID: 28314441
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and phenotypic features of CD5-negative B cell chronic lymphoproliferative disease resembling chronic lymphocytic leukemia.
    Romano C; Sellitto A; Chiurazzi F; Simeone L; De Fanis U; Raia M; Del Vecchio L; Lucivero G
    Int J Hematol; 2015 Jan; 101(1):67-74. PubMed ID: 25432435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.